Schering Entering Radiopharmaceuticals Market Via $128 Mil. Diatide Deal
This article was originally published in The Gray Sheet
Executive Summary
Schering AG is looking to accelerate its expansion into the worldwide radiopharmaceuticals market through the acquisition of Diatide. The $128 mil. cash deal was announced Sept. 20.